Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Current Liabilities ₹62 Cr₹109 Cr₹113 Cr₹78 Cr₹59 Cr

What is the latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹62 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹62 Cr
Mar2024₹109 Cr
Mar2023₹113 Cr
Mar2022₹78 Cr
Mar2017₹59 Cr

How is Total Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹62 Cr
-43.19
Mar2024 ₹109 Cr
-3.89
Mar2023 ₹113 Cr
44.60
Mar2022 ₹78 Cr
33.01
Mar2017 ₹59 Cr -

Compare Total Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,881.9 Cr 2.6% 30.4% 4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹250,390.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹111,888.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,329.0 Cr 0.9% 0% -11% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

2.6%

30.4%

4.6%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses